Outcome of accelerated corneal cross-linking with 0.25% riboflavin in progressive keratoconus patients. Yeh C, Huang K, Liang KK, Hu C, et al. Int Ophthalmol 2026;46:163.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Yeh C, Huang K, Liang KK, Hu C, et al. Outcome of accelerated corneal cross-linking with 0.25% riboflavin in progressive keratoconus patients. Int Ophthalmol 2026;46:163.
PMID: 41848799